|
Symbol
|
RMBQ5V | KZEHDU | KZJVDU | RMBAIV | ACGJTQ | BGLBIL | PUIRCH | KZXVDU | RMAXAV | Z0AXYZ | LAAHDU | Z0B18Z | RMA09V | RMBX5V | ACMVSQ | ADAATQ | ADGWTQ | ADKOTQ | RMAY9V | RMBACV |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Name | Callable Multi Defender Vonti | Autocallable Multi Barrier Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Barrier Reverse Convertible | Barrier Reverse Convertible | Worst of Reverse Convertible | Autocallable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti | Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Barrier Reverse Convertible | Callable Multi Defender Vonti | Callable Multi Defender Vonti |
|
Underlying
|
Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Roche PS | Moderna Inc. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS / Sandoz Group AG / Ypsomed Hldg. AG | ASML Hldg. N.V. / LVMH Moet Hennessy Louis Vuitton / Novo Nordisk AS (B) | Novo Nordisk AS (B) / Roche PS | Amazon.com Inc. / Novo Nordisk AS (B) / UBS Group AG | Novo Nordisk AS (B) / Philips Electronics N.V. / Roche PS / Siemens Healthineers | Novo Nordisk AS (B) / SAP SE | Eli Lilly & Co. / Novo Nordisk AS (B) | Eli Lilly & Co. / Lonza Group N / Novo Nordisk AS (B) | Bayer AG / Novo Nordisk AS (B) | Lonza Group N / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Eli Lilly & Co. / Novo Nordisk AS (B) / Ypsomed Hldg. AG | Novartis AG / Novo Nordisk AS (B) / Roche PS / Sanofi S.A. |
|
Issuer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date of maturity
|
17.11.2026 | 20.11.2026 | 30.12.2026 | 30.12.2026 | 03.09.2026 | 28.08.2026 | 17.09.2026 | 08.09.2026 | 12.10.2026 | 16.10.2026 | 28.10.2026 | 29.10.2026 | 12.05.2027 | 16.11.2026 | 23.11.2026 | 27.11.2026 | 23.09.2026 | 08.10.2026 | 14.01.2027 | 25.01.2027 |
| Bid | 41.300 | 41.650 | 39.500 | 53.50 | 49.550 | - | 52.38 | 46.800 | 71.90 | 101.84 | 73.25 | 104.29 | 68.80 | 65.80 | 73.89 | 73.46 | 64.90 | 70.50 | 70.40 | 96.70 |
| Ask | - | 42.650 | - | - | - | - | - | 47.800 | - | 102.74 | 74.25 | 105.19 | - | - | - | - | - | - | - | 97.50 |